Dosage of 3-FPO: How Researchers Are Handling the New Substance

3-FPO is one of the comparatively new research chemicals that are being studied in laboratory environments for analytical and scientific purposes. The substance is not approved for human consumption and is not approved as a medicine or foodstuff.

Nevertheless, increasing numbers of experience reports are circulating on the internet, in which people describe subjective impressions, dosage information and courses of action.

In this article, we answer your questions about the dosage of 3-FPO and give you an overview of the wealth of information gleaned from numerous user reports, reviews, and forum entries about the research chemical.

Happy reading!

Note: 3-FPO is not intended for human consumption. All described content is based on scientific sources or subjective experience reports and is not to be understood as instructions or recommendations.

Chemically, the name 3-FPO stands for 5-((3-fluorophenyl)(piperidin-2-yl)methyl)-3-methyl-1,2,4-oxadiazol hydrochloride. It is a completely synthetically produced molecule in the laboratory, which is presumed to be a stimulant – i.e., a class of substances that temporarily exhibit stimulating properties on the central nervous system.
Since 3-FPO has only recently appeared on the market as a research chemical, there are currently no scientifically confirmed data on its mechanism of action, metabolization, or toxicity. Statements about dosages therefore come exclusively from unofficial sources such as forums, experience reports, or discussion platforms and are anecdotal in nature.

3-FPO is sold as a research chemical for analytical or chemical research purposes, often with the note "not suitable for human consumption". This means:

• There are no verified dosage recommendations,
  
  

• no clinical safety data,
  
  

• the substance is neither approved as a foodstuff nor as a medicine, nor is it tested accordingly by controls,
  
  

• and there is no medical approval or supervision of its use.
  
  

Anyone who still wishes to use 3-FPO for their own research should definitely refrain from polydrug use, start the experiment with a low dose, and allow sufficient time between individual trials to prevent tolerance development, overdoses, and dependencies.

To avoid accidental overdoses, accuracy when weighing the substance is essential. The easiest way, of course, is to use pre-dosed 3-FPO tablets or pellets, as they contain a consistent amount of the active ingredient.

However, anyone researching with 3-FPO in powder form should absolutely use a high-quality precision scale that measures accurately even in the milligram range. Even minimal deviations can make a significant difference in the effect of a potent substance like 3-FPO. Dosing by eye is therefore not only inaccurate but can also have serious consequences – both for the validity of the research results and for the safety of the experimental procedure. For a potent stimulant like 3-FPO, dosing by eye is dangerous and irresponsible!

At low to moderate doses of 3-FPO, numerous users report pleasant alertness that is more pronounced and longer-lasting than with caffeine, for example, a clear head, improved concentration, good mood, more focus, and increased mental potential.

High dosages, polydrug use with other substances, and frequent use increase the risk of side effects. The negative side effects most frequently described by users for 3FPO include:

• Tachycardia & increased blood pressure

• Loss of appetite

• Sleep problems

• Dry mouth

• Increased body temperature & sweating

• Dehydration

• Nervousness, internal restlessness & tension

Responsible, careful, and well-considered handling of the substance is essential according to safer-use aspects to minimize side effects and the risk of unpleasant experiences. Therefore, for your own research projects: low doses and an absolute avoidance of polydrug use!

According to reports from online forums, the quantities used for research are usually in the low milligram range. However, the range of values mentioned is wide – an indication that the effect can strongly depend on individual factors, such as:

• Body weight and metabolic rate
  
  

• Experience with similar substances (e.g. stimulants)
  
  

• Intake of certain medications
  
  

• Quality and purity of the research chemical
  
  

• Method of consumption (oral, nasal)
  
  

• Form administered (powder, solution, tablets, spray, pellets)

Since no official reference data or clinical studies exist, all information is speculative. Numerous users state that they base their dosage on recommendations for related substances, such as methylphenidate. However, it should be noted that 3-FPO is not a medication and therefore cannot replace a medically prescribed preparation such as Ritalin!

In addition, some users report unexpectedly intense effects even at small amounts, which could indicate a high potency of 3-FPO.

From various sources and reports, the following values emerge as reference points for 3-FPO dosage – it is important that you approach the substance carefully and use a low rather than too high a dose for your research:

• Light dose: the range of approx. 5 –10 mg

• Medium dose: ~ 15 mg

• High dose: ~ 30+ mg

• Since 3-FPO is a novel and little-researched chemical, there are currently no valid dosage guidelines or limits from official bodies. Accordingly, there is no scientific data available on the effects, dosage, detectability, or consumption of the active substance from 3-FPO.

• Furthermore, due to the lack of appropriate controls, 3-FPO is not approved as a food or a medicine – and is therefore not suitable for human consumption.

• All available information comes from unofficial user sources, which are neither scientifically verified nor representative. Important: Information from the internet merely reflects individual experiences and should not be interpreted as a recommendation.

• Researchers who work with the substance as part of their own experiments should always observe Safer Use rules, consult official information and safety data sheets from the manufacturer, and regularly check the legal status, as this can change at any time.

• A. Ansari, D. N. Osser (2020). Stimulants and Other ADHD Medicines. In: Psychopharmacology: A Concise Overview, pp. 231–C5.P212.  https://doi.org/10.1093/med/9780197537046.003.0006.

• J. M. Swanson, T. L. Wigal, N. D. Volkow (2011). Contrast of Medical and Nonmedical Use of Stimulant Drugs, Basis for the Distinction, and Risk of Addiction: Comment on Smith and Farah. Psychol Bull. 2011 Sep;137(5):742–748. doi:  10.1037/a0024898.

• Mayer FP, Burchardt NV, Decker AM, Partilla JS, Li Y, McLaughlin G, et al. (2018).  "Fluorinated phenmetrazine "legal highs" act as substrates for high-affinity monoamine transporters of the SLC6 family". Neuropharmacology. 134 (Pt A): 149–157.  doi: 10.1016/j.neuropharm.2017.10.006